HealthEquity's high P/S ratio could possibly be due to market expectations for future growth. The current justification for the high ratio lies on the low chance of decreased revenues, which investors expect to uphold share price.
Despite expenses reducing earnings last year, HealthEquity's future outlook remains positive. Unusual items don't typically recur, suggesting underestimated earning potential. The firm returned to profitability this year.
Despite HealthEquity's revenue growth and share price rise over three years, short-term underperformance and negative five-year returns are concerning. Fundamental improvements are required for shareholder confidence. Analyst forecasts could shed light on the company's future.
HealthEquity股票討論區
📊⚡️📊
2024上半年營收增長18.5%,營業利潤則受成本和費用增速放緩的影響增長到0.53億,淨利潤增長到0.15億。
目前市值達到64.3億,即使今年淨利潤達到1億,市盈率仍有64倍,估值沒什麼吸引力。
• $柯爾百貨(KSS.US)$ +10.4% (Board of Directors enters into three-week exclusive negotiations with $Franchise(FRG.US)$)
• $Gitlab(GTLB.US)$ +8.5% (In reaction to earnings)
• $聯合原生態食品(UNFI.US)$ +6.9% (In reaction to earnings)
• $Dave & Buster's Entertainment(PLAY.US)$ +6.3% (In reaction to earnings)
• $G-III服裝集團(GIII.US)$ +5.6% (In reaction to earnings)
• $HealthEquity(HQY.US)$ +4.2% (In reaction to ea...
• $ChampionX(CHX.US)$: Piper Sandler Upgrades to Overweight From Neutral - PT $30 (from $28)
• $CatchMark Timber Trust Inc(CTT.US)$: Baird Upgrades to Outperform from Neutral - PT $10 (from $9)
• $EPAM Systems(EPAM.US)$: Wolfe Research Upgrades to Outperform from Peerperform - PT $390 (from $550)
• $Essent(ESNT.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $47 (from $54)
• $捷藍航空(JBLU.US)$: MKM Partners Upgrades to Neutral from Sell...
• $Beacon Roofing Supply(BECN.US)$: JPMorgan Upgrades to Neutral from Underweight - PT $68
• $HF Sinclair(DINO.US)$ : Goldman Sachs Upgrades to Neutral from Sell - PT $43 (from $32)
• $Freshpet(FRPT.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $136
• $HealthEquity(HQY.US)$ : BTIG Upgrades to Buy from Neutral - PT $85
• $美國豪斯特酒店(HST.US)$ : Jefferies Upgrades to Buy from Hold - PT $25 (from $20)
• $馬斯科(MAS.US)$ : JPMorgan...
暫無評論